Shareholder Alert: Ademi LLP investigates whether Angion Biomedica Corp. has entered into a Fair Transaction with Elicio

Provided By PR Newswire

Last update: Jan 18, 2023

MILWAUKEE, Jan. 17, 2023 /PRNewswire/ -- Ademi LLP is investigating Angion (Nasdaq: ANGN) for possible breaches of fiduciary duty and other violations of law in its transaction with Elicio.